Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS

被引:242
作者
Alimonti, JB [1 ]
Ball, TB [1 ]
Fowke, KR [1 ]
机构
[1] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3E 0W3, Canada
关键词
D O I
10.1099/vir.0.19110-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
AIDS, caused by the retroviruses human immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2), has reached pandemic proportions. Therefore, it is critical to understand how HIV causes AIDS so that appropriate therapies can be formulated. Primarily, HIV infects and kills CD4(+) T lymphocytes, which function as regulators and amplifiers of the immune response. In the absence of effective anti-retroviral therapy, the hallmark decrease in CD4(+) T lymphocytes during AIDS results in a weakened immune system, impairing the body's ability to fight infections or certain cancers such that death eventually ensues. The major mechanism for CD4(+) T cell depletion is programmed cell death (apoptosis), which can be induced by HIV through multiple pathways. Death of HIV-infected cells can result from the propensity of infected lymphocytes to form short-lived syncytia or from an increased susceptibility of the cells to death. However, the apoptotic cells appear to be primarily uninfected bystander cells and are eradicated by two different mechanisms: either a Fas-mediated mechanism during activation-induced cell death (AICD), or as a result of HIV proteins (Tat, gp120, Nef, Vpu) released from infected cells stimulating apoptosis in uninfected bystander cells. There is also evidence that as AIDS progresses cytokine dysregulation occurs, and the overproduction of type-2 cytokines (IL-4, IL-10) increases susceptibility to ACID whereas type-1 cytokines (IL-12, IFN-gamma) may be protective. Clearly there are multiple causes of CD4(+) T lymphocyte apoptosis in AIDS and therapies that block or decrease that death could have significant clinical benefit.
引用
收藏
页码:1649 / 1661
页数:13
相关论文
共 152 条
  • [11] In vivo analysis of Fas/FasL interactions in HIV-infected patients
    Badley, AD
    Dockrell, DH
    Algeciras, A
    Ziesmer, S
    Landay, A
    Lederman, MM
    Connick, E
    Kessler, H
    Kuritzkes, D
    Lynch, DH
    Roche, P
    Yagita, H
    Paya, CV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) : 79 - 87
  • [12] Dynamic correlation of apoptosis and immune activation during treatment of HIV infection
    Badley, AD
    Parato, K
    Cameron, DW
    Kravcik, S
    Phenix, BN
    Ashby, D
    Kumar, A
    Lynch, DH
    Tschopp, J
    Angel, JB
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) : 420 - 432
  • [13] CROSS-LINKING CD4 BY HUMAN IMMUNODEFICIENCY VIRUS-GP120 PRIMES T-CELLS FOR ACTIVATION-INDUCED APOPTOSIS
    BANDA, NK
    BERNIER, J
    KURAHARA, DK
    KURRLE, R
    HAIGWOOD, N
    SEKALY, RP
    FINKEL, TH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) : 1099 - 1106
  • [14] Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8
    Bartz, SR
    Emerman, M
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (03) : 1956 - 1963
  • [15] Baumler CB, 1996, BLOOD, V88, P1741
  • [16] Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events
    Blanco, J
    Barretina, J
    Ferri, KF
    Jacotot, E
    Gutiérrez, A
    Armand-Ugón, M
    Cabrera, C
    Kroemer, G
    Clotet, B
    Esté, JA
    [J]. VIROLOGY, 2003, 305 (02) : 318 - 329
  • [17] Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor γ chain signalling cytokines and type IIFN, and increases susceptibility to activation-induced apoptosis
    Borthwick, NJ
    Lowdell, M
    Salmon, M
    Akbar, AN
    [J]. INTERNATIONAL IMMUNOLOGY, 2000, 12 (07) : 1005 - 1013
  • [18] A two-step, two-signal model for the primary activation of precursor helper T cells
    Bretscher, PA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) : 185 - 190
  • [19] Biochemical pathways of caspase activation during apoptosis
    Budihardjo, I
    Oliver, H
    Lutter, M
    Luo, X
    Wang, XD
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 : 269 - 290
  • [20] Capobianchi MR, 1996, J BIOL REG HOMEOS AG, V10, P83